Sunday, 21 September 2014
Last updated 1 day ago
Jun 14 2011 | 8:28am ET
Stamford-based MKM Partners has hired Jon LeCroy, M.D., as managing director in its equity research department covering biotechnology and specialty pharmaceuticals companies. The hire marks the beginning of the company’s expansion into the healthcare sector.
LeCroy has covered the same sector at Goldman Sachs, Natixis Bleichroeder and, most recently, at Hapoalim Securities USA.
"Our move into the healthcare vertical expands MKM's research footprint," said MKM Partners CEO Richard R. Castellano. "Jon's in-depth and actionable research—and his stockpicking prowess—will make him a key resource for MKM's existing institutional equity client base and enable us to service new clients focused on investment opportunities in healthcare."
MKM Partners is an institutional equity research, sales and trading firm.
Aug 25 2014 | 11:21am ET
As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…
Credit default swaps brought down the London Whale and cost JPMorgan $6.2 billion. Here is how it happened.